Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 3
1962 2
1965 1
1966 2
1967 1
1968 2
1969 1
1970 3
1971 1
1972 2
1974 2
1975 2
1977 2
1978 1
1979 1
1980 3
1981 2
1983 1
1984 2
1985 1
1986 2
1990 2
1991 1
1992 2
1993 1
1994 2
1995 2
1996 4
1997 7
1998 8
1999 10
2000 6
2001 13
2002 9
2003 5
2004 3
2005 4
2006 4
2007 4
2008 7
2009 3
2010 9
2011 6
2012 5
2013 9
2014 15
2015 12
2016 20
2017 13
2018 17
2019 16
2020 18
2021 21
2022 10
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
Nakayama Y, Watanabe R, Murakami K, Murata K, Tanaka M, Ito H, Yamamoto W, Ebina K, Hata K, Hiramatsu Y, Katayama M, Son Y, Amuro H, Akashi K, Onishi A, Hara R, Yamamoto K, Ohmura K, Matsuda S, Morinobu A, Hashimoto M. Nakayama Y, et al. Among authors: yamamoto w. Rheumatol Int. 2022 Jul;42(7):1227-1234. doi: 10.1007/s00296-021-05086-w. Epub 2022 Mar 10. Rheumatol Int. 2022. PMID: 35266034
IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study.
Nakayama Y, Watanabe R, Yamamoto W, Ebina K, Hirano T, Kotani T, Shiba H, Katayama M, Son Y, Amuro H, Onishi A, Jinno S, Hara R, Murakami K, Murata K, Ito H, Tanaka M, Matsuda S, Morinobu A, Hashimoto M. Nakayama Y, et al. Among authors: yamamoto w. Rheumatology (Oxford). 2024 Feb 1;63(2):349-357. doi: 10.1093/rheumatology/kead299. Rheumatology (Oxford). 2024. PMID: 37354495
Hyperproinsulinemia in Japan.
Kanazawa Y, Kuzuya N, Takeuchi Y, Kubo F, Yamamoto W, Noda M. Kanazawa Y, et al. Among authors: yamamoto w. Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S143-4. doi: 10.1016/0168-8227(94)90241-0. Diabetes Res Clin Pract. 1994. PMID: 7859596 Review.
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Ebina K, Etani Y, Maeda Y, Okita Y, Hirao M, Yamamoto W, Hashimoto M, Murata K, Hara R, Nagai K, Hiramatsu Y, Son Y, Amuro H, Fujii T, Okano T, Ueda Y, Katayama M, Okano T, Tachibana S, Hayashi S, Kumanogoh A, Okada S, Nakata K. Ebina K, et al. Among authors: yamamoto w. RMD Open. 2023 Aug;9(3):e003160. doi: 10.1136/rmdopen-2023-003160. RMD Open. 2023. PMID: 37597846 Free PMC article.
On the evolution of the physiological model.
Yamamoto WS, Walton ES. Yamamoto WS, et al. Annu Rev Biophys Bioeng. 1975;4(00):81-102. doi: 10.1146/annurev.bb.04.060175.000501. Annu Rev Biophys Bioeng. 1975. PMID: 1098568 Review.
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Ebina K, Hirano T, Maeda Y, Yamamoto W, Hashimoto M, Murata K, Onishi A, Jinno S, Hara R, Son Y, Amuro H, Takeuchi T, Yoshikawa A, Katayama M, Yamamoto K, Okita Y, Hirao M, Etani Y, Kumanogoh A, Okada S, Nakata K. Ebina K, et al. Among authors: yamamoto w. Sci Rep. 2022 Jan 7;12(1):134. doi: 10.1038/s41598-021-04075-0. Sci Rep. 2022. PMID: 34997059 Free PMC article.
Contrast nasopharyngography.
Tada S, Kino M, Yamamoto W, Harada J, Kanehira C. Tada S, et al. Among authors: yamamoto w. Clin Radiol. 1977 Nov;28(6):659-62. doi: 10.1016/s0009-9260(77)80052-4. Clin Radiol. 1977. PMID: 589923
Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Hayashi S, Tachibana S, Maeda T, Yamashita M, Shirasugi I, Yamamoto Y, Yamada H, Okano T, Nishimura K, Ueda Y, Jinnno S, Saegusa J, Yamamoto W, Murata K, Fujii T, Hata K, Yoshikawa A, Ebina K, Etani Y, Yoshida N, Amuro H, Hashimoto M, Hara R, Katayama M, Okano T, Kuroda R. Hayashi S, et al. Among authors: yamamoto w. Rheumatology (Oxford). 2023 Nov 1:kead543. doi: 10.1093/rheumatology/kead543. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37924201
289 results